Boys and girls, have a bang on this -
$2.1m Novartis gene therapy to become world's most expensive drug
theguardian.com/science/201...?
Swiss drugmaker Novartis has received US approval for its spinal muscular atrophy gene therapy Zolgensma – pricing the one-time treatment at a record $2.125m.
That's two million, USD. You read that right. Yet another gene therapy thing passes the trial phase and hits the market. Bring it on.